Abstract:Background Clear cell renal cell carcinoma (ccRCC), the most common urological malignancy, has an unfavorable prognosis and an unknown mechanism of progression. Through survival analyses screening of The Cancer Genome Atlas (TCGA) dataset, we identified Visual system homeobox1 (VSX1) as a novel potential prognostic biomarker in ccRCC and subsequently investigated the oncogenic role of VSX1 in ccRCC. Methods The differential expression of VSX1 in human tumors and the clinical prognoses were analyzed in the TCGA dataset and Gene Expression Omnibus. Spearman’s correlation coefficient was determined for the correlation analysis of VSX1 expression and other genes of interest. The roles of VSX1 in cell proliferation, invasion, and migration of ccRCC cells were evaluated via the CCK-8 assay, colony formation assay, and Transwell assay, respectively. Further results were demonstrated by western blotting, immunohistochemistry, qRT-PCR, tumor sphere formation, flow cytometry, and the dual‑luciferase reporter assay. Results VSX1 mRNA upregulation was generally observed in multiple human malignancies from the TCGA database and was confirmed in ccRCC clinical specimens from our department. High VSX1 expression usually indicated that overall and disease-free survival were unfavorable for patients with ccRCC. In terms of mechanism, knockdown or overexpression of VSX1 affected ccRCC aggressiveness in vitro. The dual-luciferase reporter gene assay implied that VSX1 overexpression significantly increased the luciferase activity of TMEM44 , FKBP10 , and TRIB3 , which indicated that VSX1 promoted ccRCC invasiveness via transcriptional regulation of these genes. The significantly enhanced growth in vitro that was induced by stable VSX1 overexpression was almost restored to normal by the knockdown of FKBP10 . Conclusions This study demonstrated that VSX1 was a novel prognostic biomarker in ccRCC and that high VSX1 expression promoted cell proliferation, invasion, and migration in ccRCC via transcriptional activation of downstream target genes.

Pre-B-Cell Leukemia Transcription Factor 1 Regulates Expression of Valosin-Containing Protein, a Gene Involved in Cancer Growth

E74-like Factor 2 Regulates Valosin-Containing Protein Expression

E74-like Factor 2 Transactivates Valosin-Containing Protein Gene, a Gene Involved in Cancer Growth.

Prognostic Significance of Pre B Cell Leukemia Transcription Factor 2 (PBX2) Expression in Non-Small Cell Lung Carcinoma.

Expression of Pre B Cell Leukemia Transcription Factor (pbx) is Correlated with Prognosis and Survival of Patients with Non-Small Cell Lung Carcinoma

Valosin-Containing Protein Stabilizes Mutant p53 to Promote Pancreatic Cancer Growth

High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma

Valosin-containing Protein Regulates the Proteasome-Mediated Degradation of DNA-PKcs in Glioma Cells.

VCP Interaction with HMGB1 Promotes Hepatocellular Carcinoma Progression by Activating the PI3K/AKT/mTOR Pathway

Inhibition of VCP Modulates NF-κB Signaling Pathway to Suppress Multiple Myeloma Cell Proliferation and Osteoclast Differentiation.

Increased Expression of Valosin-Containing Protein (p97) Is Correlated With Disease Recurrence in Follicular Thyroid Cancer

Specific mutations in the D1–D2 linker region of VCP/p97 enhance ATPase activity and confer resistance to VCP inhibitors

Targeting Valosin-Containing Protein Enhances the Efficacy of Radiation Therapy in Esophageal Squamous Cell Carcinoma.

The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53

Valosin‑containing Protein Promotes Metastasis of Osteosarcoma Through Autophagy Induction and Anoikis Inhibition Via the ERK/NF‑κβ/beclin‑1 Signaling Pathway

High VSX1 Expression Promotes the Aggressiveness of Clear Cell Renal Cell Carcinoma by Transcriptionally Regulating FKBP10

Inhibiting Valosin-Containing Protein Suppresses Osteosarcoma Cell Metastasis Via AKT/nuclear Factor of Kappa B Signaling Pathway in Vitro.

XBP1s Acts as a Tumor Suppressor to Inhibit the EMT Process and Metastasis of Papillary Thyroid Cancer

CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK/p300 axis

VPS33B Modulates C-Myc/p53/mir-192-3p to Target CCNB1 Suppressing the Growth of Non-Small Cell Lung Cancer

PBX1 Participated in Estrogen Mediated Bladder Cancer Progression and Chemo-Resistance through Affecting Estrogen Receptors